Quality of Life Outcomes in Spinal Cord Stimulation

Rutgers, The State University of New Jersey6 enrolled

Overview

The investigators will be evaluating quality of life outcomes in patients who are undergoing routine spinal cord stimulator implant for uncontrolled pain. Patients will be evaluated pre and post-operatively for quality of life improvements, pain control, and functionality.

This is a prospective cohort study for patients who will be undergoing implantation of spinal cord stimulator for pain. All patient will have implantation done at University Hospital Newark or Newark Beth Israel. The data points that will be collected will be the patient's weight, BMI, and detailed questionnaires regarding disability, activity, quality of life, and depression. The first data set will be taken pre-operatively at the DOC, 90 Bergen Street, suite 8100. Those patients enrolled will have the same data taken again upon subsequent postoperative visits at 3, 6, and 12 months. Being that spinal cord stimulation is a well-documented safe procedure, the investigators do not anticipate any deviation from the standard risks of surgery. With that being said the primary safety endpoint would be if there is an increased complication rate, secondary to the procedure, greater than the current anticipated risk rate. This is a purely observational study. Patients are not being recruited for an intervention but are being recruited during routine clinical practice.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Neuropathic Pain Low Back Pain

Interventions

Spinal Cord StimulationDEVICE

Implantation of a spinal cord stimulator for the control of axial back or neuropathic pain.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with neuropathic pain or axial back pain that is not controlled by oral analgesics, opioids, and has failed conservative management. * Ages 18-90 with no ethnicity or gender predilections. Exclusion Criteria: * Patients who have spinal cord injury, multiple stimulator revisions, DRG stimulators, intrathecal pain pumps, complex regional pain syndrome, previous spinal cord stimulator implant, mechanical instability requiring fusion, myelopathy, psychological condition precluding them from complying with therapy, illegal drug abuse including heroin, cocaine, and illegally obtained prescription pills, or have previously been or are currently involved in litigation for medical malpractice.

Locations (1)

Neurologic Institute of New Jersey

Newark, New Jersey, United States

Outcomes

Primary Outcomes

The number of patients with at least 50% improvement in VAS Pain Score

The number of patients who had at least 50% improvement in VAS pain score

Time frame: 12 Months

The number of patients with at least 50% improvement in Owenstry low back disability index

The number of patients who had at least 50% improvement in disability as determined by this questionnaire.

Time frame: 12 Months

The number of patients with at least 50% improvement in WHODAS 12 disability index.

The number of patients who had at least 50% improvement in disability as determined by this questionnaire.

Time frame: 12 Months

Secondary Outcomes

The number of patients with at least 50% improvement in SF-36 quality of life score

The number of patients who had at least 50% improvement in quality of life as determined by this questionnaire.

Time frame: 12 months

The number of patients with at least 50% improvement in beck depression inventory

The number of patients who had at least 50% improvement in depression as determined by this questionnaire.

Time frame: 12 Months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.